Stay updated on MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial

Sign up to get notified when there's something new on the MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    A new revision entry v3.5.4 has been added to the Study Record Versions, and the previous revision v3.5.3 has been removed from the history. This updates the revision history to reflect the latest submission.
    Difference
    0.1%
    Check dated 2026-05-18T03:50:59.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page’s revision label updates from “v3.5.2” to “v3.5.3,” reflecting a change in the site’s display/versioning rather than the underlying study record.
    Difference
    0.1%
    Check dated 2026-04-26T08:24:02.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-19T01:23:28.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-21T08:30:13.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added to the history log, and Revision: v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-06T18:27:50.000Z thumbnail image
  9. Check
    103 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added and Revision: v3.4.1 has been removed.
    Difference
    0.1%
    Check dated 2026-02-13T12:13:01.000Z thumbnail image

Stay in the know with updates to MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial page.